Exelixis vs Gilead Sciences: revenue, profit, margins and growth compared
Exelixis brought in $2.3B of revenue in fiscal 2025, Gilead Sciences $29.4B in fiscal 2025. Revenue changed by +7.0% at Exelixis and +2.4% at Gilead Sciences on the year before, so Exelixis grew faster. Exelixis kept 33.7% of its revenue as net profit, Gilead Sciences 28.9%. Free cash flow was $875.8M at Exelixis and $9.5B at Gilead Sciences.
Fiscal years as each company reports them; the two may end in different months.
Questions about Exelixis and Gilead Sciences
Which is bigger by revenue, Exelixis or Gilead Sciences?
Gilead Sciences is bigger by revenue: $29.4B in fiscal 2025, against $2.3B for Exelixis in fiscal 2025.
Which keeps more of its revenue as profit, Exelixis or Gilead Sciences?
Exelixis had a net margin of 33.7% in fiscal 2025; Gilead Sciences had 28.9% in fiscal 2025.
Which grew revenue faster, Exelixis or Gilead Sciences?
In their latest fiscal years revenue changed by +7.0% at Exelixis and +2.4% at Gilead Sciences.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.